CN101947269B - Medicine for treating viral herpes - Google Patents

Medicine for treating viral herpes Download PDF

Info

Publication number
CN101947269B
CN101947269B CN2010102752495A CN201010275249A CN101947269B CN 101947269 B CN101947269 B CN 101947269B CN 2010102752495 A CN2010102752495 A CN 2010102752495A CN 201010275249 A CN201010275249 A CN 201010275249A CN 101947269 B CN101947269 B CN 101947269B
Authority
CN
China
Prior art keywords
medicine
herpes
injection
illness
ketoconazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010102752495A
Other languages
Chinese (zh)
Other versions
CN101947269A (en
Inventor
刘安庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102752495A priority Critical patent/CN101947269B/en
Publication of CN101947269A publication Critical patent/CN101947269A/en
Application granted granted Critical
Publication of CN101947269B publication Critical patent/CN101947269B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a medicine for treating viral herpes, comprising the following components: chlorhexidine acetate, golden cypress, acyclovir, chloramphenicol injection, ketoconazole, propionic acid clobetasol and hexadecadrol injection. The medicine in the invention has effects of viral resistance, heat clearing, blood cooling, detumescence and relieveing pain. The clinical observation proves that the cure rate of the medicine is up to 96.69%; and the medicine of the invention has the advantages of remarkable efficacy and quick effect taking, can control and remit state of an illness after being taken, has certain pharmacological property and applicability, and has wide popularization and clinical practice value.

Description

A kind of medicine of treating virus infected herpes
Technical field
The present invention relates to the medical medicine field, be specifically related to have a kind of medicine of significant curative effect to the virus infected herpes patient.
Background technology
Virus infected herpes (HerpesSimplex) is popular more extensive on the our times, and treatment is the disease of difficulty comparatively.It is a kind of by the virogenetic viral dermatosis of virus infected herpes, divides herpes simplex and herpes zoster.Herpes simplex (herpessimplex) is the dermatosis due to a kind of herpes simplex virus; Invade well in mucocutaneous intersection; Show as limitation bunch collection property phlycten; Herpes zoster (herpeszoster) is caused by herpesvirus that then along the intensive phlysis and the neuralgia of a side peripheral nerve zonal distribution, regional nodes's enlargement is the acute viral dermatosis of principal character.
Herpes simplex is caused by herpes simplex virus; Human body is its unique natural reservoir (of bird flu viruses); When Abwehrkraft des Koepers descends; Promote primary disease to take place, show as vesicle in the epidermis, epidermis necrosis, multinuclear epithelium giant cell, acidophilic intranuclear inclusion and remarkable neutrophilic leukocyte and lymphocyte inflammatory infiltration on the pathology.Herpes zoster be since in the body varicella zoster virus of hiding be activated, this virus is confessed one's crime behind the subinfection patient, hides for a long time in the body neurocyte, brings out during immunologic hypofunction, its histopathology is similar with the former, but latter's inflammation is heavy than the former.
Especially be multiple with the herpes zoster, the herpes zoster onset has pain suddenly or earlier, and damaging is that the big phlysis of gregariousness Semen phaseoli radiati takes place on the imflammatory erythema, and the pimple of appearance, bulla or blood blister are arranged; Skin is normal between each group, and erythra is often done zonal distribution along peripheral nervous, and one-sided property is seen more; See that with intercostal nerves and nervi trigeminus district its friendship is upper limb brachial plexus nerve and lower limb sciatic nerve district, idol can influence eye more; Cause keratitis, iritis, panophthalmitis etc., 2~March of the course of disease or more of a specified duration, the normal enlargement of regional nodes; Tenderness is arranged, and severe patient is heatable, and pain is in various degree arranged.
Primary disease is sent out in the women well, middle-aged and elderly people, infant and the colony that has a delicate constitution.
But for a long time, still there is not specific drug for the treatment of this disease both at home and abroad.Western medicine is main with anti-inflammatory analgetic class medicine or amcinonide mainly for the treatment of this disease, but has long, defective such as therapeutic effect the is undesirable course of treatment; And it is complicated to treat the also common west that exists of this sick Chinese medicine, the defective of slow curative effect.
Summary of the invention
To the deficiency that exists in the above prior art, the invention provides a kind of instant effect, analgesic effect obviously, the medicine of the treatment virus infected herpes of short treating period.
The present invention realizes through following technical scheme:
A kind of medicine of treating virus infected herpes, described medicine be by following raw materials according by weight formulated:
Chlorhexidine acetate 2.5~7.5g;
Cortex Phellodendri 3~12g;
Acyclovir 2~5g;
Chloromycetin injection 0.5~1.5g;
Ketoconazole 0.05~0.1g;
Clobetasol propionate 0.035~0.05g;
Dexamethasone injection 2mg~10mg.
Wherein the material source of chlorhexidine acetate and Cortex Phellodendri is taken from bacterium ointment only; The material source of ketoconazole and clobetasol propionate is taken from PIKANGWANG.Acyclovir, Chloromycetin injection and dexamethasone injection are all purchased from pharmacy.
Beneficial effect of the present invention is: after chlorhexidine acetate, Cortex Phellodendri, acyclovir, Chloromycetin injection, ketoconazole, clobetasol propionate and dexamethasone injection are proportionally mixed, have antiviral, clearing away heat and cooling blood, the effect of reducing swelling and alleviating pain.The cure rate of this medicine of clinical observation proof is up to 96.69%, and is evident in efficacy, and instant effect is controlled and mitigate the disease after using at once, has the certain pharmacological and the suitability, has and promotes widely and clinical value.
The specific embodiment
One, ingredient
Chlorhexidine acetate 2.5~7.5g;
Cortex Phellodendri 3~12g;
Acyclovir 2~5g;
Chloromycetin injection 0.5~1.5g;
Ketoconazole 0.05~0.1g;
Clobetasol propionate 0.035~0.05g;
Dexamethasone injection 2mg~10mg.
Wherein, wherein the material source of chlorhexidine acetate and Cortex Phellodendri is taken from bacterium ointment only; The material source of ketoconazole and clobetasol propionate is taken from PIKANGWANG.Acyclovir, Chloromycetin injection and dexamethasone injection are all purchased from pharmacy.
Two, usage and consumption
Mix above-mentioned medicine and stir, be stained with light salt brine wiping affected part gently with dry towel earlier, the outer uniformly thing of applying medicinal lotion or ointment in back gets final product in the affected part, three~four times on the one, will fully recover in four~eight days.
Three, taboo and points for attention
1, avoids the water flushing from the beginning of the affected part.
2, the irritable food that avoids pungent food.
3, be difficult for overworked.
4, orally-ingestible not.
5, unsuitable life-time service.
Four, function cures mainly
Be mainly used in herpes simplex, herpes zoster due to the viral infection, simultaneously, infant skin wrinkle are hindered also has certain curative effect.
Five, clinical data
996 routine virus infected herpes and infant skin wrinkle injury person.Before using this medicine, the patient had all adopted the medicine of symptom such as general treatment virus infected herpes, but curative effect not too obviously or effect relatively poor.
Six, clinical observation
After using medicine of the present invention, patients with mild spreading 4-5 days, antalgesic-antipruritic can be fully recovered immediately; Heavier patient used about 10 days, just can fully recover.
Seven, treatment situation
This medicine is treated 996 people altogether during the application in nearly ten years, wherein cure 963 people, 33 people of no positive effect, cure rate is up to 96.69%, no positive effect be merely 3.31%.
Wherein the treatment time of 963 recovery from illness needs is added up as follows:
347 people of recovery from illness in 5 days
419 people of recovery from illness in 6 days
143 people of recovery from illness in 7 days
48 people of recovery from illness in 8 days
6 people of recovery from illness more than 9 days.
Eight, model case
Case one: the king so-and-so man 76 years old;
Readme is the hot pain of time-out scalp Shuo just, and herpes appears in the top of the head two days later, diabrosis tailing edge right side cheek and auricle; Under infect to cervical region and omoplate portion, after come downwards to oxter and waist side of body portion again, sharp ache; Surplus county hospital, city ten, do not see day to be clearly better, day by day increase the weight of on the contrary.
On July 19th, 2008, the sufferer area accounts for about 20% of health area, and herpes is buff more greatly, and the Shuo pain is violent, dysphoria, and with heating, anorexia, tired mind is transferred the affected part of loosing, four times on the one, continuous four days with medicine-feeding.
July 23, area does not have the expansion sign, and herpes all caves in, and rash point darkish complexion is the cicatrix shape, and Shuo reduces sharply bitterly, and medication did not have heating after one day, and the mental status is clearly better.Continue with medicine-feeding three days.
July 26, cicatrix comes off, and skin surface is ruddy, and is even with the affected part mild pain, other transference cures.State of an illness recovery from illness.
Case two: Chen woman 47 years old
Readme is sick to be sent out in waist, has played several herpes simplexes before this, owing to have a bath again after the mistaken diagnosis, sudden diffusion then occurs, infects to advancing one week of waist, reaches pudendum down down to the portion of rising, and the lamellar bullous eruption then occurs., following cloudy redness is festered, and the Shuo pain is violent, and seek medical advice and medicine and use folk prescription among the people all not have positive effect in many places, however the state of an illness has the trend of aggravation to the greatest extent.
On February 8th, 2010, in one week of waist, the portion of rising reaches pudendum down, the lamellar bullous eruption occurs, and following cloudy redness is festered, and causalgia is violent, dysphoria, and the red tongue tongue falls, and floating pulse is counted accurately.
Use this medicine five days.Outer wiping affected part, four times on the one.
February 13, medication second day, symptom just has obviously and alleviates, and during further consultation, area does not have expansion, herpes depression, the major part trace that scabbed, following cloudy redness disappears, and pain obviously alleviates, and mental status was good, medication four days.
February 15, phone was made a round of visits, and the wound surface cicatrix is all eliminated, and the colour of skin is light red, and idol is with mild pain, and other symptoms need not medication completely without the recovery from illness of, the state of an illness.
Case three, the Meng, the man was 6 months
The readme initial stage is found child's dysphoria, crys constantly, and sleeplessness day and night, anorexia removes hospital admission, finds the red and swollen diabrosis in cervical region and oxter, has mucus to flow out, and touches the affected part aggravation of then crying, and to oral medicine and medicine for external use four days, does not see positive effect in hospital.
On June 19th, 2010, cervical region and oxter are red and swollen, and tangible wrinkle are arranged, and have hyalomucoid to flow out, and child's dysphoria touches the affected part aggravation of crying.
Wipe the affected part outward with this medicine, three times on the one.
June 21, cervical region and oxter are red and swollen eliminates, and skin smooth is ruddy, other symptoms completely without.State of an illness recovery from illness.
Nine, conclusion
The present invention is the hybrid medicine of chlorhexidine acetate, Cortex Phellodendri, acyclovir, Chloromycetin injection, ketoconazole, clobetasol propionate and dexamethasone injection, has antiviral, clearing away heat and cooling blood, the effect of reducing swelling and alleviating pain.The cure rate of this medicine of clinical observation proof is up to 96.69%, and is evident in efficacy, and instant effect is controlled and mitigate the disease after using at once, has certain pharmacological, and the suitability has and promotes widely and clinical value.

Claims (1)

1. medicine of treating virus infected herpes, it is characterized in that described medicine be by following raw materials according by weight formulated:
Chlorhexidine acetate 2.5~7.5g;
Cortex Phellodendri 3~12g;
Acyclovir 2~5g;
Chloromycetin injection 0.5~1.5g;
Ketoconazole 0.05~0.1g;
Clobetasol propionate 0.035~0.05g;
Dexamethasone injection 2mg~10mg.
CN2010102752495A 2010-09-03 2010-09-03 Medicine for treating viral herpes Expired - Fee Related CN101947269B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102752495A CN101947269B (en) 2010-09-03 2010-09-03 Medicine for treating viral herpes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102752495A CN101947269B (en) 2010-09-03 2010-09-03 Medicine for treating viral herpes

Publications (2)

Publication Number Publication Date
CN101947269A CN101947269A (en) 2011-01-19
CN101947269B true CN101947269B (en) 2012-06-27

Family

ID=43450977

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102752495A Expired - Fee Related CN101947269B (en) 2010-09-03 2010-09-03 Medicine for treating viral herpes

Country Status (1)

Country Link
CN (1) CN101947269B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045043A (en) * 2018-07-20 2018-12-21 福建霞浦财富天成工贸有限公司 It is a kind of to treat antiherpetic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1239169C (en) * 2003-06-16 2006-02-01 深圳太太药业有限公司 Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method

Also Published As

Publication number Publication date
CN101947269A (en) 2011-01-19

Similar Documents

Publication Publication Date Title
CN101947269B (en) Medicine for treating viral herpes
CN103393942B (en) Traditional Chinese medicine preparation for treating anal fissure
CN101428079B (en) Chinese-medicinal wine for treating cervical vertebra disease
CN102949643B (en) Ointment for skin nursing and dermatitis treatment
CN102240357B (en) Medicament for treating tinnitus and preparation method thereof
CN103638380B (en) A kind of Chinese medicine preparation for the treatment of verruca plana
CN1442172A (en) External use medicine for treating blister sore
CN102283925A (en) Traditional Chinese medicine for treating neurodynia resulted from herpes zoster
CN104027425B (en) Medicine for external use of a kind of Acne treatment and preparation method thereof
CN104666420A (en) A medicine for treating rhinitis
CN104138453B (en) A kind of Chinese medicine preparation treating facial nerve paralysis
CN104606406B (en) A kind of traditional Chinese medicinal ointment and preparation method thereof of external application prevention of allergic rhinitis
CN103893297B (en) A kind of Chinese medicinal ointment for the treatment of sinusitis
CN105998335A (en) Tranquilizing traditional Chinese medicine composition gel and preparation method thereof
Singh et al. Concept of dermatological disorders in Ayurveda
CN102416157B (en) Acupoint patch prepared from Chinese medicines, and preparation method for acupoint patch
CN105031526A (en) Traditional Chinese medicine for treating neurodermatitis and preparation method thereof
CN105079750A (en) Traditional Chinese medicine for treating facioplegia and preparation method thereof
CN105434988A (en) Traditional Chinese medicine composition for treating neurodermatitis
CN1600327B (en) External pasted medication for curing nervus vascularis headache and perparation method of production
CN105943584A (en) Medicine for treating dental ulcer
Zhu Clinical study on acupuncture in treating perimenopausal insomnia
CN103720924B (en) One treats dysmenorrhea external omphaloidean ointment
CN113491716A (en) Medicine for nursing and treating herpes zoster and preparation method thereof
CN102526216A (en) Traditional Chinese medicine composition for treating psoriasis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120627

Termination date: 20140903

EXPY Termination of patent right or utility model